Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
Current knowledge on Multiple Sclerosis (MS) etiopathogenesis encompasses complex interactions between the host’s genetic background and several environmental factors that result in dysimmunity against the central nervous system. An old-aged association exists between MS and viral infections, capabl...
Main Authors: | Gianmarco Bellucci, Virginia Rinaldi, Maria Chiara Buscarinu, Roberta Reniè, Rachele Bigi, Giulia Pellicciari, Emanuele Morena, Carmela Romano, Antonio Marrone, Rosella Mechelli, Marco Salvetti, Giovanni Ristori |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.755333/full |
Similar Items
-
MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
by: Rosella Mechelli, et al.
Published: (2021-05-01) -
A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
by: Benedetta Angeloni, et al.
Published: (2021-04-01) -
The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
by: Maria Chiara Buscarinu, et al.
Published: (2019-08-01) -
Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
by: Rosella Mechelli, et al.
Published: (2020-01-01) -
SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets [version 1; peer review: 1 approved, 2 approved with reservations]
by: Gianmarco Bellucci, et al.
Published: (2020-08-01)